Patients who received lidocaine at the time of corticosteroid injection for hand and wrist conditions experienced lower pain intensity compared with those who did not receive lidocaine, according to presented results.
Catalyst OrthoScience announced FDA 510(k) clearance of the Catalyst shoulder fracture system for patients with proximal humerus fractures, according to a company press release.
Injuries of the knee resulting in damage to cartilage affect approximately 900,000 Americans annually, resulting in more than 200,000 surgical procedures. These injuries are frequently associated with pain, diminished joint functionality, and reduced quality of life.
The U.S. Food and Drug Administration (FDA) has approved a request for a supplemental Biologics License Application for the repair of knee cartilage defects using arthroscopic delivery of the autologous cultured chondrocytes on a porcine collagen membrane.
ACL reconstruction with hamstring tendon graft may yield decreased knee flexion strength vs. reconstruction with patellar tendon graft.
